<p> β-Lactones are present in a number of biologically interesting natural products. They also have inherent reactivity due to their strained ring system and act as important synthetic intermediates. In this current work, we focus on the development of an efficient stereoselective route for the synthesis of β-lactones. A Tandem Evans-type Aldol Lactonization (TEAL) method was developed and various di- and tri-substituted β-lactones were successfully synthesized in a one pot process, using the lithium enolates of N-acetyl- (2-8) and N-propionyl- (2-20) thiazolidine-2-thione and a variety of ketones with moderate to good yields. Substitution of these N-acyl thiazolidine-2-thiones with chiral N-acetyl and N-propionyl thiazolidine-2-thiones (2-41 and 2-42 respectively) produced β-lactones with good enantioselectivity (up to 83% e.e.) and also showed an improvement of diastereoselectivity indicating the potential of the developed method. </p> / Thesis / Master of Science (MSc)

Escalating consumer concerns have placed the poultry industry under mounting pressure to reduce the use of chemotherapeutic agents as feed additives. One possible alternative receiving increased attention is the use of immunomodulators such as β-glucan. A pilot study evaluated the effects of a yeast derived β-glucan (Auxoferm YGT) on growth performance and immune response of broiler chickens. Day-old chicks were fed a diet containing 0, 0.02, or 0.1% yeast β-glucan. On days 7 and 14 post-hatch, body weight and relative immune organ weights were measured, peripheral blood was collected to determine heterophil to lymphocyte (H:L) ratios, and small intestinal sections were sampled to evaluate relative gene expression. The addition of β-glucan had no influence on growth. Dietary β-glucan supplementation modulated the expression of interleukin (IL)-8, IL-18, interferon (IFN)-γ and inducible nitric oxide synthase (iNOS) in the small intestine. A subsequent study was conducted to investigate the effects of dietary β-glucan on broiler chick (1440 birds) performance and immune response during a mixed Eimeria infection (day 8 of age). Measurements were taken and samples collected on days 4, 7, 10, 14 and 21 post-hatch. The results from this study show that β-glucan supplementation did not negatively impact performance. The addition of β-glucan to the diet resulted in reduced gross lesion severity and increased H:L ratios. The gene expression results suggest that β-glucans are capable of skewing the host immune response toward aTh1 mediated response and consequently down-regulating the Th2 mediated response. / Master of Science

Yes / Heterozygous loss of function mutations in the type II bone morphogenetic protein receptor (BMPR-II), a member of the transforming growth factor (TGF-β) receptor family, underlie the majority of familial cases of pulmonary arterial hypertension (PAH). The TGF-β1 pathway is activated in PAH and inhibitors of TGF-β1 signaling prevent the development and progression of PAH in experimental models. However, the effect of currently utilized therapies on the TGF-β pathway is not known. Prostacyclin analogues remain the first line of treatment for clinical PAH. We hypothesized that these agents effectively decrease the activity of the TGF-β1 pathway. Beraprost sodium (BPS), a prostacyclin analogue selectively inhibits proliferation in a dose-dependent manner in mouse primary pulmonary arterial smooth muscle cells (PASMCs) harbouring a pathogenic BMPR2 nonsense mutation in both the presence and absence of TGF-β1 stimulation. This study demonstrates that this agent inhibits TGF-β1–induced SMAD-dependent and -independent signaling via a PKA dependent pathway by reducing the phosphorylation of SMADs 2 and 3 and p38MAPK proteins. Finally, in a monocrotaline (MCT)-induced rat model of PAH, which is associated with increased TGF-β signaling, this study confirms that treprostinil (TPS), a stable prostacyclin analogue, inhibits the TGF-β pathway by reducing SMAD3 phosphorylation. Taken together, these data suggest that prostacyclin analogues inhibit dysregulated TGF-β signaling in vitro and in vivo and reduce BMPR-II-mediated proliferation defects in mutant mice PASMCs. / The authors acknowledge financial support from the British Heart Foundation, United Kingdom (Programme Grant 1-2004-357 to R.C.T. and N.W.M.), a Heptagon Life Science Proof of Concept Fund (grants KCL24 and KCL25 to M.T.N. and R.C.T., respectively), and the Great Britain Sasakawa Foundation (grant B70 to M.T.N.)

Yes / There is a need to develop asymmetric routes to functionalised β-lactams, which remain the most important group of antibacterials. Here we describe biocatalytic and protein engineering studies concerning carbapenem biosynthesis enzymes, aiming to enable stereoselective production of functionalised carbapenams with three contiguous chiral centres. Structurallyguided substitutions of wildtype carboxymethylproline synthases enable tuning of their C-N and C-C bond forming capacity to produce 5-carboxymethylproline derivatives substituted at C-4 and C-6, from amino acid aldehyde and malonyl-CoA derivatives. Use of tandem enzyme incubations comprising an engineered carboxymethylproline synthase and an alkylmalonylCoA forming enzyme (i.e. malonyl-CoA synthetase or crotonyl-CoA carboxylase reductase) can improve stereocontrol and expand the product range. Some of the prepared 4,6-disubstituted-5-carboxymethylproline derivatives are converted to bicyclic β-lactams by carbapenam synthetase catalysis. The results illustrate the utility of tandem enzyme systems involving engineered crotonases for asymmetric bicyclic β-lactam synthesis.

Οι αιμοσφαιρινοπάθειες συγκαταλέγονται ανάμεσα στις πιο κοινές μονογονιδιακές διαταραχές παγκοσμίως, συμπεριλαμβανομένης της β-θαλασσαιμίας και της δρεπανοκυτταρικής αναιμίας. Η επανενεργοποίηση των γονιδίων της γ-σφαιρίνης φαίνεται να είναι μια ενδιαφέρουσα θεραπευτική προσέγγιση για τους ασθενείς που πάσχουν από β-τύπου αιμοσφαιρινοπάθειες. Ορισμένες φαρμακευτικές ουσίες έχουν τη δυνατότητα να επάγουν παροδικά την έκφραση των γονιδίων της γ-σφαιρίνης γεγονός που βελτιώνει το φαινότυπο των ασθενών λόγω των υψηλότερων επιπέδων HbF που παρατηρούνται. Η μόνη φαρμακευτική ουσία που έχει εγκριθεί από τον FDA και χρησιμοποιείται ευρύτατα σε ασθενείς που πάσχουν από β-τύπου αιμοσφαιρινοπάθειες και συγκεκριμένα από δρεπανοκυτταρική αναιμία είναι η HU. Παρά το γεγονός ότι στην πλειονότητα των ασθενών παρατηρείται αύξηση της παραγωγής HbF μετά από αγωγή με HU (Steinberg et al. 1997), τα επίπεδα αύξησης διαφέρουν αρκετά μεταξύ των ασθενών που πάσχουν από β-θαλασσαιμία και δρεπανοκυτταρική αναιμία(Patrinos and Grosveld 2008). Σύμφωνα με τους Borg και συνεργάτες, το γονίδιο KLF10 φαίνεται να σχετίζεται με την αύξηση των επιπέδων της HbF και την ανταπόκριση ασθενών με β-τύπου αιμοσφαιρινοπάθειες σε θεραπεία με HU(Borg et al. 2012). Στην παρούσα μελέτη διερευνήθηκε η πιθανή συσχέτιση των SNP rs319133 και rs11552577, που εδράζονται στο γονίδιο KLF10, με αυξημένα επίπεδα HbF και η αξιολόγηση αυτών ως φαρμακογονιδιωματικοί δείκτες, που σχετίζονται με τη μεταβλητότητα των επιπέδων της HbF ως απόκριση στη θεραπεία με HU. Χρησιμοποιήθηκαν ασθενείς που πάσχουν από βαριά β-θαλασσαιμία, ενδιάμεση β-θαλασσαιμία, μη-θαλασσαιμικοί ασθενείς και διπλά ετερόζυγοι ασθενείς για β-θαλασσαιμία και δρεπανοκυτταρική αναιμία. Η μέθοδος γονοτύπησης που χρησιμοποιήθηκε και για τους δύο πολυμορφισμούς ήταν η PCR-RFLP. Η απουσία του πολυμορφισμού rs319133 φαίνεται να σχετίζεται με αυξημένα επίπεδα HbF στους ασθενείς που χαρακτηρίζονται από ενδιάμεση β-θαλασσαιμία συγκριτικά με ασθενείς που πάσχουν από βαριά β-θαλασσαιμία (p=0.04). Επίσης παρατηρείται μια στατιστική τάση συσχέτισης χειρότερης ανταπόκρισης στην αγωγή με HU στους διπλά ετερόζυγους ασθενείς 96 για β-θαλασσαιμία και δρεπανοκυτταρική αναιμία. Για τον δεύτερο πολυμορφισμό που μελετήθηκε δεν παρατηρήθηκαν στατιστικά σημαντικές διαφορές. Τα δεδομένα της παρούσας μελέτης υποδεικνύουν συσχέτιση του γονιδίου KLF10 με αυξημένα επίπεδα HbF. Μελέτες σε πολυπληθέστερες ομάδες θα μπορούσαν να οδηγήσουν στον εντοπισμό και άλλων πολυμορφισμών που σχετίζονται με αυξημένη έκφραση των γονιδίων της γ-σφαιρίνης. / Hemoglobinopathies are amongst the most common single gene disorders worldwide, including the thalassemias and sickle cell disease (SCD). Reactivation of the human γ-globin genes would be a therapeutic intervention for β-type hemoglobinopathies patients. Some drugs and compounds can transiently induce γ-globin gene expression and improve the disease phenotype by augmenting HbF accumulation. Only HU (hydroxyurea) is approved from the FDA and is widely used to treat patients with β-type hemoglobinopathies, in particular sickle cell disease. Although the majority of patients show an increase of HbF production upon HU treatment(Steinberg et al. 1997), the level of HbF increase differs considerably among β-thalassemia and SCD patients(Patrinos and Grosveld 2008). According to Borg et al, KLF10 appears to be significantly associated with high HbF and it may act as an important pharmacogenetic biomarker for β-type hemoglobinopathies patients who are treated with HU(Borg et al. 2012). The aim of our study was to elucidate whether there is an association of the SNPs namely rs3191333 and rs11552577 in KLF10 gene with increased levels of HbF and with response to HU treatment in β-hemoglobinopathies patients. We analyzed samples of β-thalassemia major patients, of β-thalassemia intermedia patients, of healthy (non-thalassemic) donors and samples of SCD/β–thalassemia patients who have been treated with HU. Genotyping was carried out by using PCR-RFLP. The lack of rs3191333 is associated with increased HbF levels in β–thalassemia intermedia compared to β– thalassemia major patients (p=0.04). Also, it is shown a statistical trend of worse response to HU treatment in compound heterozygote β–thalassemia-SCD patients. As far as rs11552577 is concerned no statistically significant differences were observed. Our data show that KLF10 gene is strongly associated with HbF levels. Further analyses could possibly reveal novel variants which are associates with increased expression of γ-globin genes.

This thesis examines the synthesis of conformationally constrained β-amino acids and β- peptides, and the electron transfer properties of the latter when immobilised on gold. Additionally, cross metathesis on gold was investigated as a method for surface functionalisation. Chapter One introduces the concepts of electron transfer in nature, how it is facilitated by the secondary structure in α-peptides, and why β-peptides might be useful for studying electron transfer. This is followed by a discussion of the properties of β-peptides, including the enhanced stability and variety of helical secondary structures and the greater potential for functionalisation of the peptide backbone when compared to α-peptides. Finally, the conformational constraints of ring-systems on cyclic amino acids is discussed, with reference to the stabilising effect of these compounds on peptide secondary structures. Chapter Two describes the electrochemical analysis of β-hexapeptides immobilised on gold. The chapter is prefaced by a discussion of the important electron transfer mechanisms for peptides, the fabrication of peptide-gold self-assembled monolayer (SAM) interfaces, and the electron transfer in helical α-peptides. β-Peptides containing an electroactive ferrocene moeity were immobilised on gold and studied using cyclic voltammetry and chronoamperometry. The latter method was used to examine the dependence of the electron transfer rate on overpotential, thereby determining the likely mode of electron transfer through the β-peptides SSβ₆Fc, Fcβ₆SS and SC₁₅β₆Fc. These peptides exhibited very weak dependence on overpotential, characteristic of electron transfer behaviour of an electron hopping mechanism (which is also thought to occur in helical α-peptides). Both the dipole moment of the peptides and the structure of the sulfurlinker group were found to be important in determining the rate of electron transfer. Conversely, the equivalent α-peptide SSα₆Fc exhibited electron transfer behaviour characteristic of the less efficient tunnelling mechanism, which is thought to operate in strand-like peptides. Chapter Three examines the application of cross metathesis, using a Grubbs' second generation catalyst, as a means to functionalise olefin-terminated self-assembled monolayers on gold. Abstract iv Firstly, an introduction into the limited published research on cross metathesis on both planar surfaces and nanoparticles is given. Olefin-terminated thiol 3.18, suitable for immobilisation on gold, and solution phase olefin-terminated ferrocene 3.10 were synthesised as reactants for cross metathesis studies. An analytical methodology was developed involving the cross metathesis of surface-immobilised 3.18 with ferrocene 3.10 in dichloromethane, whereby the concentration of electroactive cross metathesis product 3.22 was monitored electrochemically as a function of time. The concentration of surface-immobilised product 3.22 was determined by integration of the oxidation peak area and found to be highly dependent on both the concentration of immobilised olefin reactant 3.18 and reaction time. Furthermore, the surface concentration of ferrocenyl model disulfide 3.21 and thiol 2.18 decayed markedly upon addition of Grubb's catalyst, as revealed by the decrease in the oxidation peak area, which suggested that catalystmediated desorption was occurring. Chapter Four details the solution-phase synthesis of ferrocene- and thiol-functionalised β- hexapeptides used in both the electron transfer studies described in chapter two, and in the determination of secondary structure using circular dichroism and NMR techniques. The synthesis of simple model compounds 4.14, 4.16 and 4.18 established the incompatibility of the deprotection of methyl and benzyl ester protecting groups with protected-thiol and disulfide linkers, leading to the use of N-hydroxysuccinmide-activated sulfur-linkers 4.20 and 4.22 in further synthesis. A number of β-hexapeptides were synthesised by amide coupling of β- tripeptides functionalised at the N- and C-termini. Structural studies of the methanol soluble β- hexapeptide 4.60 suggested that the covalent attachment of ferrocene moeity to the C-terminus of a β-peptide did not disrupt the formation of a 14-helix in solution. β-peptides containing functionality at both the C- and N-termini (such as SSβ₆Fc, SSβ₆Et and acetyl-protected SC₁₅β₆Fc) were not suitable for solution phase structural studies; however, molecular modelling suggested that helical conformations are the most stable these β-peptides in solution phase. Chapter Five outlines the synthesis of novel cyclic β-amino acids by two different general synthetic routes. The first uses an efficient conjugate addition/fluorination reaction of α,β- unsaturated esters with lithiated chiral secondary amines to prepare the novel cyclopentyl- and cyclohexyl-based fluorinated β-amino acids 2.43a and 2.43b. The high diastereoselectivity of this reaction, which introduces two stereocentres into the achiral unsaturated esters, is directed by the configuration of the attacking amine. The second methodology utilizes the versatile ringclosing metathesis reaction in the synthesis of novel cyclic β-amino acids. A stereoselective Abstract v trans-alkylation of olefinic β-amino acids gave the required β-dienes 5.62 and 5.77. Optimised cyclisation yields were achieved with a Grubb's 2nd generation catalyst for diene 5.62 and Grubb's 1st generation catalyst for diene 5.77, to give the trans-cycloheptyl- and cyclooctylbased β-amino acids 5.63 and 5.78, respectively. The attempted synthesis of cyclononyl-based β-amino acid 5.87 using both catalysts yielded only cyclic dimer products 5.88 and 5.89. The trans configuration of the 5.62 diene was confirmed by x-ray crystallography. Chapter Six is an experimental chapter and outlines the electrochemical setup and analysis, and the synthesis, purification and characterisation of compounds described in this thesis.

Kočová, K.: Natural compounds and their β-secretase inhibitory activity, Diploma thesis, Charles University in Prague, Faculty of Pharmacy in Hradci Králové, Department of Pharmaceutical Botany and Ecology, Hradec Králové 2015, 83 p. Data used in this Diploma Thesis have been taken from foreigner scientific literature. It provides the whole summary of natural compounds with β-secretase inhibitory activity. First chapter Alzheimer's disease briefly describes a definition, risk factors and symptomatology of the disease. Most of this chapter characterizes an etiopathology of the disease focused on amyloid theory. Finally there are also mentioned current approaches to therapy of Alzheimer's disease and those, which stay in clinical trials. Next part is dedicated to physiological functions and substrates of the β-secretase. This diploma thesis evaluates the current state of scientific research of synthetic inhibitors of β-secretase, describes the most important methods of testing inhibition and activity of β-secretase in vitro and outlines the issue of development of new inhibitors using in silico method. Main part of this work consists of the list of natural compounds with β- secretase inhibitory activity. This part is structured according to particular types of primary and secondary metabolites....

The diploma thesis was focused on evidence of selected somatic mutations in genes ALK (Anaplastic lymphoma receptor tyrosine kinase), BRAF (v-Raf murine sarcoma viral oncogene homolog B1) and β-catenin (CTNNB1) through molecular - genetic methods in the target group of neuroectodermal tumors (neuroblastoma, medulloblastoma, brain tumors, paraganglioma and pheochromocytoma). Some of them are already considered as prognostic indicators which help to identify the subtype of various tumors and on the basis of this molecular - biological classification choosing the appropriate treatment. The genetic material of 133 patients was used for the analysis divided by the type of cancer. The presence of the mutation was detected in seven cases, of which two of them beloged to the gene BRAF, one to the gene ALK and four to the gene β-catenin. The subject of research in the cases of this genes were hotspot mutation sites. The purpose was to confirm the presence of the mutation in the hotspots and contribute to the studies which are aimed at the introduction of more suitable treatment through the inhibitors of mutated genes. Keywords: ALK, BRAF, β-catenin (CTNNB1), neuroectodermal tumors, sequencing, MLPA

Le TGF-β (Transforming growth factor-β) régule de nombreux processus cellulaires et la dérégulation de la signalisation du TGF-β est associée à divers troubles vasculaires. Dans le laboratoire du Dr Génot, le TGF-β a été découvert comme étant le facteur capable d’induire la formation de podosomes organisés en superstructures, appelées rosettes, dans les cellules endothéliales aortiques. Les podosomes sont des structures à base d’actine, formées de façon transitoire, capables de dégrader la matrice extracellulaire (MEC). Dans ce projet, nous avons étudié les récepteurs du TGF-β et les mécanismes moléculaires associés, impliqués dans la formation des podosomes en réponse au TGF-β dans le modèle des cellules endothéliales aortiques bovines primaires (BAEc). Deux types de récepteurs du TGF-β de type I (TβRI), ALK5 et ALK1, régulent les réponses au TGF-β dans les cellules endothéliales, ALK5 étant un récepteur ubiquitaire et ALK1 étant un récepteur dont l’expression est restreinte aux cellules endothéliales. Ces deux récepteurs contrôlent l'activation de protéines Smads distinctes et réagissent à la stimulation par le TGF-β. ALK5 active Smad2/3 et ALK1 active Smad1/5/8. BMP9 est un autre ligand d’ALK1. ALK1 n'active pas Smad2/3 dans les BAEc et BMP9 inhibe la formation des podosomes induite par le TGF-β. La stimulation de Smad1/5/8 par le traitement au TGF-β est induite par la signalisation du complexe ALK1/ALK5. En utilisant une approche à base de siRNA ciblant l’un ou l’autre des TβRI, l’induction des podosomes par le TGF-β est supprimée. Cependant, la transfection des TβRI constitutivement actifs (CA) a montré que l’expression du CA-ALK5 se substitue au TGF-β pour induire des podosomes alors que l'expression du CA-ALK1 est inefficace. Concernant la signalisation en aval des TβRI, l'implication des protéines Smads a également été étudiée dans la régulation du processus. La diminution d’expression de Smad3 abolit complètement la formation des podosomes induite par le TGF-β alors que la déplétion des protéines Smad1 ou Smad5 augmente leur formation. La surexpression des protéines Smad2 ou Smad3, elles aussi, dans une certaine mesure, se substituent aux signaux du TGF-β, alors que la surexpression de Smad1 diminue la formation des podosomes en réponse au TGF-β. Le TGF-β est également capable de moduler la formation d'un autre type de structure d'actine appelée étoiles d’actine. Le nombre de cellules présentant des étoiles d'actine diminue avec le traitement au TGF-β. Cependant, dans les cellules déficientes en Smad3, la formation de ces étoiles d’actine semble être stimulée par le TGF-β. Dans les BAEc, la rigidité ainsi que les protéines de la MEC semblent aussi moduler la formation des podosomes et des étoiles d'actine. Ces travaux démontrent que, bien que le TGF-β stimule à la fois ALK5 et ALK1, la signalisation d’ALK5 induit la formation des podosomes et la signalisation d’ALK1 atténue ce signal. Les voies canoniques, par l’intermédiaire de la régulation des protéines Smads, contribuent à la formation des podosomes induits par le TGF-β dans les BAEc. / Transforming growth factor-β (TGF-β) regulates a wide array of cellular processes and deregulation of TGF-β signalling is associated with various vascular disorders. In the Lab of Dr. Génot it was discovered that TGF-β induces the formation of podosomes organised in superstructures called rosettes, in aortic endothelial cells. Podosomes are transient actin-based structures able to degrade the extracellular matrix (ECM). In this project we have studied TGF-β receptors and associated molecular mechanisms underlying podosome formation in response to TGF-β in primary bovine aortic endothelial cells (BAEc). Two types of TGF-β type I receptors (TβRI), ALK5 and ALK1, regulate TGF-β responses in endothelial cells. ALK5 being an ubiquitous receptor and ALK1 being endothelial cell specific. Both ALK5 and ALK1 receptors control the activation of distinct Smad proteins, and both are responsive to TGF-β stimulation. ALK5 activates Smad 2/3 and ALK1 activates Smad 1/5/8. BMP9 is another ligand for ALK1. ALK1 doesn’t activate Smad2/3 in BAEc and ALK1 inhibits TGFβ-induced podosome formation. Smad1/5/8 stimulation by TGF-β treatment is induced through ALK1/ALK5 complex signalling. Using a knockdown approach, at the TβRI level, TGF-β induction of podosomes was inhibited. However, transfection of constitutively active (CA) TβRI showed that CA-ALK5 expression bypassed the TGF-β requirement for podosome induction whereas CA-ALK1 expression was ineffective. Looking downstream of TβRI signalling, the involvement of Smad proteins was also analysed in terms of podosome formation. Smad3 depletion completely abolished TGFβ-induced podosome formation whereas depletion of Smad1 or Smad5 proteins enhanced the TGFβ-induced podosome response. When overexpressed, Smad2 or Smad3, to some extent, bypassed TGFβ signals, whereas Smad1 overexpression diminished the TGFβ-induced podosome response. TGF-β also modulated the formation of another type of actin structure named actin-stars. The number of cells presenting actin-stars decreased with TGF-β treatment. However, in Smad3 depleted cells the formation of these actin-stars seemed to be stimulated by TGF-β. In BAEc stiffness and ECM proteins also seemed to modulate podosome and actin star formation. This project establishes that although TGF-β stimulates both ALK5 and ALK1, ALK5 signalling triggers podosome formation and ALK1 mitigates this signal. The canonical pathways through Smad protein regulation are important for TGF-β induced podosome in BAEc.

Magnesidin is a magnesium chelate of the 3-hexanoyl and 3-octanoyl tetramic acid derivatives isolated from Psuedomonas magensiorubra. Its activity against grampositive bacteria was found to be a specific target for Gingivitis, a dental plaque.Although the synthesis of magnesidin has been reported earlier, it was not reproducible. The highly polar nature and it’s ability to exhibit tautomerization makes their chemical behavior complex and difficult to predict its structure. A variety of reactions and an in depth understanding of the chemical structure is necessary to attain the synthesis of these compounds. This dissertation focuses on addressing the attempts towards the synthesis of Magnesidin by identifying the important intermediates necessary for the synthesis as β- keto esters, α,β-unsaturated amino esters. The focus of the work has been addressed by developing a TAG molecule approach, which is similar to the concept of solid phase synthesis except for the fact that the TAG molecule can be identified under UV and also can be detected using various spectroscopic techniques. Microwave synthesis has been explored and applied in to the synthesis of benzyl mono and di bromination, 1,3- benzodioxoles have been established. The benzyl mono bromination is applied to synthesize the TAG molecule, which is then applied in developing a method of synthesis for β-keto esters. The azide approach was used to synthesize the α,β- unsaturated amides, which are another essential class of compounds in the synthesis of magnesidin.